StockpollyBeta
Get App
Popularity #1,075
RPD · NASDAQ · Software - Infrastructure

Rapid7 (RPD)

Sells vulnerability, detection, and response security software consolidated into one AI-driven platform.

$12.70
After hours−0.15 (−1.13%)
At close$12.85(+3.01%)

  1. Hsbc Holdings PLC Purchases 86,623 Shares of Rapid7, Inc. $RPD

    Defense World

  2. Rapid7, Inc. (RPD) Presents at Citi's 2026 Global TMT Conference Transcript

    Seeking AlphaEarnings

  3. CORRECTION -- Quoin Pharmaceuticals Announces FDA Grants Rare Pediatric Disease Designation for QRX003 in Peeling Skin Syndrome

    GlobeNewsWireClinical

  4. Quoin Pharmaceuticals Announces FDA Grants Rare Pediatric Disease Designation for QRX003 in Peeling Skin Syndrome

    GlobeNewsWireClinical

  5. Rapid7 Inc (RPD) Shares Fall 7.8% -- What GF Score of 54 Tells Investors

    GuruFocusMarket move

  6. Rapid7 Finds Nearly Two-Thirds of Vulnerabilities Exploited in Q2 2026 Required No User Interaction to Initiate

    GlobeNewsWireOther

  7. Is Rapid7 (RPD) a Great Value Stock Right Now?

    Zacks Investment Research

  8. Rapid7 Inc (RPD) Shares Fall 8.2% -- What GF Score of 59 Tells Investors

    GuruFocus

  9. Rapid7 Analysts Boost Their Forecasts Following Better-Than-Expected Q2 Earnings

    Benzinga

  10. Rapid7 Q2 Earnings Call Highlights

    MarketBeat

  11. Rapid7 (RPD) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

    Zacks Investment Research

  12. Rapid7, Inc. (RPD) Q2 2026 Earnings Call Transcript

    Seeking Alpha

  13. Rapid7 (RPD) Q2 Earnings and Revenues Top Estimates

    Zacks Investment Research

  14. Stay Ahead of the Game With Rapid7 (RPD) Q2 Earnings: Wall Street's Insights on Key Metrics

    Zacks Investment Research

  15. Rapid7 to Report Second Quarter 2026 Financial Results on August 10

    GlobeNewsWire

  16. Niagen Bioscience Receives Exclusive U.S. FDA Rare Pediatric Disease (RPD) Designation and European Medicines Agency Orphan Medicinal Product Designation (OMPD) for NB4168 for the Treatment of Ataxia Telangiectasia (A-T)

    Business Wire

  17. Rapid7 (RPD) Moves 7.6% Higher: Will This Strength Last?

    Zacks Investment Research

  18. Reveal Expands European Offerings with Private Deployment, AI-Powered Review and Logikcull's Government Transparency Solutions

    Business Wire

  19. Rapid7: New CEO And AI Opportunities Draw Attention

    Seeking Alpha

  20. Rapid7 Appoints Wael Mohamed Chief Executive Officer; Corey Thomas to Become Executive Chairman

    GlobeNewsWire